Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Imunon, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 17 | 18 | +1 |
| Shares | 399.7K | 412.5K | +12.8K (+3.2%) |
| Value | $515.1K | $402.9K | −$112.2K (−21.8%) |
New holders (2)
Institutions that held Imunon, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 11 | $11 | 0.00% |
| FMR LLC | 6 | $6 | 0.00% |
Sold out (1)
Institutions that held Imunon, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| NewSquare Capital LLC | 10 | $13 |